Transthyretin cardiac amyloidosis in Saudi Arabia and the Middle East: insights, projected prevalence and practical applications

• Dania Mohty,
• Dania Mohty,
• Mohamed H. Omer,
• Omar Ahmad,
• Islam Alayary,
• Talal Alzahrani,
• Thibaud Damy,
• Bahaa Fadel,
• Bahaa Fadel

Affiliations

Dania Mohty

Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Dania Mohty

College of Medicine, Al Faisal University, Riyadh, Saudi Arabia

Mohamed H. Omer

School of Medicine, Cardiff University, Cardiff, United Kingdom

Omar Ahmad

College of Medicine, Al Faisal University, Riyadh, Saudi Arabia

Islam Alayary

Rare Diseases Medical Affairs, Pfizer Inc., Jeddah, Saudi Arabia

Talal Alzahrani

Department of Medicine, College of Medicine, Taibah University, Medina, Saudi Arabia

Thibaud Damy

Referral Center for Cardiac Amyloidosis, Department of Cardiology, Mondor Amyloidosis Network, GRC Amyloid Research Institute, Clinical Investigation Center 006, DHU A-TVB INSERM U955 all at CHU Henri Mondor, UPEC, Créteil, France

Bahaa Fadel

Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Bahaa Fadel

College of Medicine, Al Faisal University, Riyadh, Saudi Arabia